If however GSDME-mediated pyroptosis of tumor cells is excessive, as seen in response to chimeric antigen receptor (CAR) T cell therapy, dying cells release alarmins, activate caspase-1/GSDMD pathway in recruited macrophages, and cause systemic cytokine release syndrome, a common complication of CAR T cell therapy (23). This evidence concerns the gene GSDMD and neoplasm.